GB1468815A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1468815A
GB1468815A GB4865073A GB4865073A GB1468815A GB 1468815 A GB1468815 A GB 1468815A GB 4865073 A GB4865073 A GB 4865073A GB 4865073 A GB4865073 A GB 4865073A GB 1468815 A GB1468815 A GB 1468815A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
medicament
compositions
vymatt
heading
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4865073A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vymatt SA
Original Assignee
Vymatt SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vymatt SA filed Critical Vymatt SA
Priority to GB4865073A priority Critical patent/GB1468815A/en
Publication of GB1468815A publication Critical patent/GB1468815A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1468815 Pharmaceutical compositions VYMATT SA 15 Jan 1975 [18 Oct 1973] 48650/73 Heading A5B A pharmaceutical composition comprises a continuous hydrophobic phase in which there is dispersed an inert water-insoluble powder the particles of which carry an adsorbed hydrophilic solution or dispersion of a medicament. As medicament, mention is made of urea, antibiotics, enzymes, cortico steroids and many others. The compositions are for topical use.
GB4865073A 1973-10-18 1973-10-18 Pharmaceutical compositions Expired GB1468815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4865073A GB1468815A (en) 1973-10-18 1973-10-18 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4865073A GB1468815A (en) 1973-10-18 1973-10-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1468815A true GB1468815A (en) 1977-03-30

Family

ID=10449408

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4865073A Expired GB1468815A (en) 1973-10-18 1973-10-18 Pharmaceutical compositions

Country Status (1)

Country Link
GB (1) GB1468815A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0121712A1 (en) * 1983-03-03 1984-10-17 The Dow Chemical Company Sustained release compositions from cellulose ethers
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4664841A (en) * 1981-02-27 1987-05-12 Ricoh Co., Ltd. Fine particle substance-containing non-aqueous dispersions
US4699777A (en) * 1985-08-21 1987-10-13 Schering Corporation Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
FR2721512A1 (en) * 1994-06-28 1995-12-29 Maurice Jacob Formulation and process for the preparation of spheroids based on solutions of vegetable origin
EP1361866A1 (en) * 2001-02-23 2003-11-19 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
FR2851918A1 (en) * 2003-03-06 2004-09-10 Galenix Innovations Powder for giving improved biodispersibility and solubility, comprises that it is impregnated with a mixture of hydrophobic and hydrophilic liquids having an active material as a solution in one phase and a suspension in the other

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485091A (en) * 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4664841A (en) * 1981-02-27 1987-05-12 Ricoh Co., Ltd. Fine particle substance-containing non-aqueous dispersions
EP0121712A1 (en) * 1983-03-03 1984-10-17 The Dow Chemical Company Sustained release compositions from cellulose ethers
US4699777A (en) * 1985-08-21 1987-10-13 Schering Corporation Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
FR2721512A1 (en) * 1994-06-28 1995-12-29 Maurice Jacob Formulation and process for the preparation of spheroids based on solutions of vegetable origin
EP1361866A1 (en) * 2001-02-23 2003-11-19 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
EP1361866A4 (en) * 2001-02-23 2007-10-17 Cima Labs Inc Emulsions as solid dosage forms for oral administration
FR2851918A1 (en) * 2003-03-06 2004-09-10 Galenix Innovations Powder for giving improved biodispersibility and solubility, comprises that it is impregnated with a mixture of hydrophobic and hydrophilic liquids having an active material as a solution in one phase and a suspension in the other
WO2004080381A2 (en) * 2003-03-06 2004-09-23 Sarl Galenix Innovations Impregnated powder improving bioavailability and/or solubility and method of production
WO2004080381A3 (en) * 2003-03-06 2005-07-28 Sarl Galenix Innovations Impregnated powder improving bioavailability and/or solubility and method of production

Similar Documents

Publication Publication Date Title
GB1404583A (en) Urea compositions and methods of preparation thereof
EP0454044A3 (en) Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance
IL101241A (en) Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
EP0171528A3 (en) Controlled release pharmaceutical preparations
IE35391L (en) Vitamin a -containing preparations
CA1012065A (en) Pharmaceutical compositions for stimulation of cardiovascular functions containing the antibiotic x-537a and its derivatives
IE36611B1 (en) Propanolamine derivatives their preparation and therapeutic compositions containing the same
GB1403584A (en) Control medicaments
GB1468815A (en) Pharmaceutical compositions
CA1030554A (en) PROCESS FOR THE PREPARATION OF .alpha.,.beta. - UNSATURATED NITRILES AND PERFUME COMPOSITIONS CONTAINING THE SAME
IE42951L (en) Injectable antibiotics compositions
IL47753A0 (en) Novel triester derivatives of the antibiotic substance sf-837 m1,their preparation and pharmaceutical compositions containing them
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1483650A (en) Pharmaceutical preparations based on mesterolone
IL45344A0 (en) 16alpha-methyl-pregna-1,4,9(11)-triene-3,20-diones as medicaments,new processes for the preparation of these products,and pharmaceutical compositions
CA944106A (en) Agglomeration of pigment particles and compositions utilizing same
GB1474749A (en) Pharmaceutical preparations based on cyproterone
CA931953A (en) 2,(2',6'-dichlorophenyl)1,3-thiazine-4-one, methods of producing the said substance and preparations containing it as an active ingredient
CA1024988A (en) Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them
NL7511662A (en) PROCESS FOR THE PREPARATION OF 1-SUBSTITUTED DERIVATIVES OF 6'N-METHYL-3'-4'-DIDEOXYKANAMYCIN B, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT.
AU6787687A (en) Symmetrical O-substituted dioximes of benzo-fused beta- diketocycloalkylenes, the processes for their preparation and their application as drugs
CA874437A (en) 18-METHYL-9.beta.,10.alpha.-STEROIDS OF THE ANDROSTANE SERIES, METHODS OF PRODUCING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS AND METHODS OF PRODUCING THE SAID PREPARATIONS
CA945544A (en) 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS
CA807142A (en) 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING THE SAME, PHARMACEUTIC PREPARATIONS CONTAINING SAID 9.beta.,10.alpha.-STEROIDS AS ACTIVE SUBSTANCES AND METHODS OF PRODUCING SAID PREPARATIONS
AU487492B2 (en) Medicament preparations and vehicles therefor

Legal Events

Date Code Title Description
PS Patent sealed
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19950114